SA 1018. Mr. DeMINT (for himself, Mr. Inhofe, Mr. Brownback, Mr. Martinez, Mr. Vitter, and Mr. Coburn) submitted an amendment intended to be proposed by him to the bill S. 1082, to amend the Federal Food, Drug, and Cosmetic Act to reauthorize and amend the prescription drug user fee provisions, and for other purposes; as follows:

In section 214(b)(3)(B) of the bill, insert ``, except with respect to the drug Mifeprex (mifepristone), such assessment shall be submitted 6 months after the applicant is so notified'' before the period at the end.


(As printed in the Congressional Record for the Senate on May 2, 2007.)